10 Disease assessment and management of the vasculitides

Abu-Shakra, 1994, Outcome of polyarteritis nodosa and Churg-Strauss syndrome. An analysis of twenty-five patients, Arthritis and Rheumatism, 37, 1798, 10.1002/art.1780371214 Adu, 1987, Polyarteritis and the kidney, Quarterly Journal of Medicine, 62, 221 Bacon, 1995, VITAL (Vasculitis Integrated Total Assessment Log) assessment of vasculitis, Clinical and Experimental Rheumatology, 13, 275 Braitman, 1996, Predicting clinical states in individual patients, Annals of Internal Medicine, 125, 406, 10.7326/0003-4819-125-5-199609010-00008 Brennan, 1996, A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study, British Medical Journal, 313, 471, 10.1136/bmj.313.7055.471 Bumgardner, 1993, New immunosuppressive agents, Gastroenterology Clinics of North America, 22, 421, 10.1016/S0889-8553(21)00076-5 Calabrese, 1995, Therapy of resistant systemic necrotizing vasculitis: Polyarteritis, Churg-Strauss syndrome, Wegener's granulomatosis, and hypersensitivity vasculitis group disorders, Rheumatic Disease Clinics of North America, 21, 41, 10.1016/S0889-857X(21)00369-0 Cohen, 1995, Persistence of antineutrophil cytoplasmic antibodies (ANCA) in asymptomatic patients with systemic polyarteritis-nodosa or Churg-Strauss-syndrome-follow-up of 53 patients, Clinical And Experimental Rheumatology, 13, 193 Cohen Tervaert, 1990, Prevention of relapses of Wegener's granulomatosis by treatment based on anti-neutrophil cytoplasmic antibody titre, Lancet, 336, 709, 10.1016/0140-6736(90)92205-V Exley, 1995, Short form 36 in vasculitis, Clinical and Experimental Immunology, 101, 63 Exley, 1997, Development and initial validation of the vasculitis damage index (VDI) for the standardised clinical assessment of damage in the systemic vasculitides, Arthritis and Rheumatism, 40, 371, 10.1002/art.1780400222 Exley, 1997, Damage as an index of disease severity in systemic vasculitis, British Journal of Rheumatology, 36, S43 Fortin, 1995, Small changes in outpatient lupus activity are better detected by clinical instruments than by laboratory tests, Journal of Rheumatology, 22, 2078 Fries, 1980, Measurement of patient outcome in arthritis, Arthritis and Rheumatism, 23, 137, 10.1002/art.1780230202 Gladman, 1992, Cross-cultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus, Journal of Rheumatology, 19, 608 Gladman, 1996, The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus, Arthritis and Rheumatism, 39, 363, 10.1002/art.1780390303 Gordon, 1993, Relapses in patients with a systemic vasculitis, Quarterly Journal of Medicine, 86, 779 Guillevin, 1988, Clinical findings and prognosis of polyarteritis nodosa and Churg Strauss angiitis: a study in 165 patients, British Journal of Rheumatology, 27, 258, 10.1093/rheumatology/27.4.258 Guillevin, 1995, Arthritis and Rheumatism, 38, 1638, 10.1002/art.1780381116 Hagen, 1994, Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin, Clinical Nephrology, 43, 351 Hoffman, 1990, Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide, American Journal of Medicine, 89, 403, 10.1016/0002-9343(90)90367-M Hoffman, 1992, Wegener's granulomatosis: an analysis of 158 patients, Arthritis and Rheumatism, 116, 488 Jennette, 1994, Nomenclature of systemic vasculitides: proposal of an international consensus conference, Arthritis and Rheumatism, 37, 187, 10.1002/art.1780370206 Kallenberg, 1990, Criteria for disease activity in Wegener's granulomatosis: a requirement for longitudinal clinical studies, APMIS, 37, 10.1111/j.1600-0463.1990.tb05725.x Kerr, 1993, Limited prognostic value of changes in antineutrohil cytoplasmic antibody titre in patients with Wegener's granulomatosis, Arthritis and Rheumatism, 36, 365, 10.1002/art.1780360312 Ledermann, 1996, Peripheral blood stem cell transplantation in common solid tumours: passing phase or new era?, Clinical Oncology, 8, 209, 10.1016/S0936-6555(05)80653-3 Lesavre, 1996, Serial ANCA testing has limited value during the follow up of disease activity in patients with ANCA-associated vasculitis, Sarcoidosis Vasculitis and Diffuse Lung Disorders, 13, 246 Leib, 1979, Immunosuppressive and corticosteroid therapy of periarteritis nodosa, American Journal of Medicine, 67, 941, 10.1016/0002-9343(79)90634-X Lockwood, 1993, Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy, Lancet, 341, 1620, 10.1016/0140-6736(93)90759-A Luqmani, 1993, Controlled trial of pulse vs continuous cyclophosphamide (CY) and prednisolone (P) in the treatment of systemic vasculitis, Arthritis and Rheumatism, 36, S96 Luqmani, 1994, Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis, Quarterly Journal of Medicine, 87, 671 Luqmani, 1996, Vasculitis Integrated Total Assessment Log (VITAL): a system for clinical evaluation of vasculitis, Arthritis and Rheumatism, 39, S67 Olsen, 1992, Validity and precision of a vasculitis activity index (VAI), Arthritis and Rheumatism, 35, S164 Mason, 1994, Glomerulonephritis: Diagnosis and treatment, British Medical Journal, 309, 1557, 10.1136/bmj.309.6968.1557 Nassonov, 1995, Serum neopterin concentrations in Wegener's granulomatosis correlate with vasculitis activity, Clinical and Experimental Rheumatology, 13, 353 Rasmussen, 1995, European therapeutic trials in ANCA-associated vasculitis: disease scoring, consensus regimens and proposed clinical trials, Clinical and Experimental Immunology, 101, S29, 10.1111/j.1365-2249.1995.tb06161.x Reinhold-Keller, 1994, Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis, Arthritis and Rheumatism, 37, 919, 10.1002/art.1780370622 Ritchie, 1968, Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis, Quarterly Journal of Medicine, 37, 393 Scott, 1994, Classification and epidemiology of systemic vasculitis, British Journal of Rheumatology, 33, 897, 10.1093/rheumatology/33.10.897 Sneller, 1995, An analysis of forty two Wegener's granulomatosis patients treated with methotrexate and prednisone, Arthritis and Rheumatism, 38, 608, 10.1002/art.1780380505 Symmons, 1995, Disease assessment indices: activity, damage and severely, Baillières clinical Rheumatology, 9, 267, 10.1016/S0950-3579(05)80190-6 Talar-Williams, 1996, Cyclophosphamide induced cystitis and bladder cancer in patients with Wegener's granulomatosis, Annals of Internal Medicine, 124, 477, 10.7326/0003-4819-124-5-199603010-00003 Ware, 1992, The MOS 36 item Short Form Health Survey (SF-36): I Conceptual framework and item selection, Medical Care, 30, 473, 10.1097/00005650-199206000-00002